JUN 02, 2016 8:00 AM PDT

WEBINAR: CE-SELEX: Isolating High Affinity Aptamers Using Capillary Electrophoresis

Sponsored by: Sciex, Sciex
Speaker

Abstract
     SELEX is a process that selects DNA or RNA from a random library of sequences based on their affinity for a target molecule.  These high affinity ligands, called aptamers, have great potential for use as drugs or diagnostic agents.  Traditionally, SELEX selection is performed using filters, panning or affinity chromatography separations and there are drawbacks to these traditional approaches.  They often require 8-15 selection rounds before a significant fraction of the pool shows affinity for the target and they can create the possibility of selecting for non-specific binders with affinity for the stationary support.
     This presentation focuses on a SELEX procedure that uses capillary electrophoresis to perform selections (CE-SELEX).  In this procedure a random sequence DNA library is incubated with the target in an injection vial.  The mixture is injected onto the capillary and a separation voltage is applied.  The size or charge of DNA with affinity for the target changes upon binding the target, inducing a mobility shift.  This mobility shift allows binding and non-binding sequences to be collected into separate vials.  Binding sequences are PCR amplified generating a new pool for further rounds of enrichment.  
     Highly selective aptamers have been identified with dissociation constants in the low nanomolar to high picomolar range for large protein targets such as IgE and HIV-RT.  More recently, aptamers have been identified with affinity for smaller targets such as neuropeptide Y and N-methylmesoporphyrin.  An important advantage of CE-SELEX results from the high efficiency, high selectivity separations characteristic of CE.  This increased separation power enhances the rate of enrichment between rounds, greatly shortening the SELEX process.  Selection takes place in free solution, minimizing non-specific interactions, increasing the abundance of high affinity aptamers in the final DNA pool.

Show Resources
You May Also Like
JUN 09, 2021 7:00 AM PDT
C.E. CREDITS
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
OCT 20, 2021 10:00 AM PDT
C.E. CREDITS
OCT 20, 2021 10:00 AM PDT
Date: October 20, 2021 Time:10:00am (PDT), 1:00pm (EDT) As the prevalence of Diabetes continues to rise in many areas across the globe, healthcare providers continue to look for methods that...
JUN 08, 2021 9:00 AM PDT
JUN 08, 2021 9:00 AM PDT
Date: June 8, 2021 Time: 9:00am PDT Reducing the spread of highly infectious and deadly diseases within the population, vaccine development is crucial in saving millions of lives each year....
OCT 12, 2021 9:00 AM PDT
C.E. CREDITS
OCT 12, 2021 9:00 AM PDT
Date: October 12, 2021 Time: 9:00am (PDT), 12:00pm (EDT) SCIEX’s next-generation Biologics Explorer software is an innovative platform for the comprehensive and deep characterization o...
OCT 27, 2021 6:00 AM PDT
C.E. CREDITS
OCT 27, 2021 6:00 AM PDT
Date: October 27, 2021 Time: 6:00 AM PDT, 9:00 AM EDT Etanercept is a recombinant Fc fusion protein therapeutic that has a complex distribution of post-translation modifications (PTM), such...
Loading Comments...
Show Resources